Loading…
Palisade Bio, Inc. is projected to rise to $2.04 by 2027, a +4% move from its current price of $1.96. PALI is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $1.87 | $1.96 | $2.05 | +0.06% |
| Jul 14 | $1.84 | $1.96 | $2.09 | +0.11% |
| Jul 15 | $1.81 | $1.96 | $2.12 | +0.17% |
| Jul 16 | $1.79 | $1.96 | $2.15 | +0.22% |
| Jul 17 | $1.78 | $1.97 | $2.18 | +0.28% |
| Jul 18 | $1.76 | $1.97 | $2.20 | +0.34% |
| Jul 19 | $1.74 | $1.97 | $2.22 | +0.39% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.74 | $1.97 | $2.22 | +0.39% |
| Week 2 | $1.67 | $1.98 | $2.34 | +0.78% |
| Week 3 | $1.61 | $1.98 | $2.44 | +1.18% |
| Week 4 | $1.57 | $1.99 | $2.53 | +1.57% |
| Week 5 | $1.53 | $2.00 | $2.61 | +1.97% |
| Week 6 | $1.50 | $2.01 | $2.69 | +2.37% |
| Week 7 | $1.47 | $2.01 | $2.77 | +2.77% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Palisade Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing oral phosphodiesterase-4 inhibitor prodrugs designed for targeted delivery to the terminal ileum and colon in the United States. Its lead clinical product candidate is PALI-2108, which is in phase 1b clinical trial to treat patients with inflammatory bowel disease, including ulcerative colitis and Fibrostenotic Crohn's disease.
The company has a research collaboration and license agreement with Giiant Pharma, Inc. for the development, manufacture, and commercialization of its compounds; license agreement with the Regents of the University of California for sole purpose of maintaining the Newsoara Co-Development; and a co-development and distribution agreement with Newsoara Biopharma Co., Ltd. The company was founded in 2001 and is headquartered in Denver, Colorado.
It is categorized in the Healthcare sector.
Palisade Bio, Inc. (PALI) is a Healthcare stock currently trading at $1.97 per share, with a market cap of $342.35M and a rank of 3417. The near-term forecast shows the average price for 2026 at $1.97, rising to $2.05 in 2027 and $2.42 in 2028, with a 2029 average of $3.49.
In the longer term, the forecast projects an average price of $3.61 in 2030 with an ROI of 83.3%, then $6.12 in 2040 with an ROI of 210.4%, and $12.10 in 2050 with an ROI of 514%. Sentiment progresses from Neutral in 2026–2027 to Bullish from 2028 onward.
A major floor 28.2% below — a decisive break under it would weaken the trend.
The nearest floor, 14.3% below — buyers have tended to step in here.
The nearest ceiling, 13.8% above — a clean break opens room to run.
A major ceiling 42.9% above — clearing it would confirm fresh momentum.
Key PALI support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of PALI market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.02 | Sell | $2.00 | Sell |
| MA 10 | $2.04 | Sell | $2.00 | Sell |
| MA 20 | $1.92 | Buy | $1.96 | Sell |
| MA 50 | $1.92 | Buy | $1.94 | Buy |
| MA 100 | $1.93 | Buy | $1.91 | Buy |
| MA 200 | $1.87 | Buy | $1.90 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 50.41 | Neutral |
| Stoch RSI (14) | 21.33 | Neutral |
| CCI (20) | 20.36 | Neutral |
| Williams %R (14) | -62.79 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | 1.03 | Buy |
| Bollinger %B (20,2) | 0.56 | Neutral |
| Stochastic %K (14) | 37.21 | Neutral |
| TRIX (15) | 0.21 | Buy |
| Awesome (5,34) | 0.10 | Buy |
| Ultimate (7,14,28) | 42.58 | Neutral |
| Momentum (10) | 0.16 | Buy |
| Aroon Osc (25) | 48.00 | Buy |
| Hull MA (9) | 1.99 | Sell |
| ADX (14) | 9.88 | Neutral |
| ATR (14) | 0.08 | Info |
The 30-day technical picture shows bullish sentiment overall. RSI14 is 50, with the 50-day simple moving average at $1.94 and the 200-day simple moving average at $1.83. Key support is at $1.68 and resistance at $2.23. The 30-day price range runs from a low of $1.40 to a high of $2.77. Annualized volatility is 100%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.49 | $1.96 | $2.57 | 0% | Neutral | |
| $1.52 | $2.04 | $2.94 | +4% | Neutral | |
| $1.58 | $2.22 | $3.38 | +13% | Neutral | |
| $2.16 | $3.16 | $5.04 | +61% | Bullish | |
| $2.21 | $3.36 | $5.55 | +72% | Bullish | |
| $1.84 | $2.91 | $4.95 | +49% | Bullish | |
| $2.01 | $3.28 | $5.73 | +67% | Bullish | |
| $1.91 | $3.22 | $5.78 | +64% | Bullish | |
| $1.99 | $3.46 | $6.34 | +76% | Bullish | |
| $2.67 | $4.77 | $8.94 | +144% | Bullish | |
| $2.53 | $5.21 | $10.64 | +166% | Bullish | |
| $4.74 | $10.53 | $24.23 | +437% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $1.49 | $1.96 | $2.33 | +0.00% |
| August 2026 | $1.66 | $2.00 | $2.49 | +1.84% |
| September 2026 | $1.70 | $2.06 | $2.62 | +3.32% |
| October 2026 | $1.60 | $1.97 | $2.53 | -4.66% |
| November 2026 | $1.54 | $1.90 | $2.48 | -3.16% |
| December 2026 | $1.56 | $1.95 | $2.57 | +2.36% |
Click any year to see its month-by-month PALI forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, PALI is projected to trade between $1.49 and $2.57, averaging $1.96 — a potential gain of 0% from today's $1.96. A consolidation phase looks the most probable path here.
Palisade Bio, Inc.'s 2027 outlook centres on $2.04, within a $1.52 to $2.94 range. That is up +4% on the projected 2026 average. That marks a +4% change versus current levels. Price action looks broadly range-bound.
By 2028, PALI could reach as high as $3.38, with a base case around $2.22 and support toward $1.58 — roughly +13% from $1.96. A consolidation phase looks the most probable path here.
Expect PALI to range from $2.16 to $5.04 through 2029. The $3.16 average target implies a +61% move from current prices. That is up +42% on the projected 2028 average. Momentum favours further upside here.
The PALI price prediction for 2030 points to an average of $3.36 (low $2.21, high $5.55) — a potential gain of +72% on today's $1.96. Buyers look set to stay in control over this stretch.
In 2031, PALI is projected to trade between $1.84 and $4.95, averaging $2.91 — a potential gain of +49% from today's $1.96. That is -13% versus the projected 2030 average. Momentum favours further upside here.
Palisade Bio, Inc.'s 2032 outlook centres on $3.28, within a $2.01 to $5.73 range. That is up +12% on the projected 2031 average. That marks a +67% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, PALI could reach as high as $5.78, with a base case around $3.22 and support toward $1.91 — roughly +64% from $1.96. Momentum favours further upside here.
Expect PALI to range from $1.99 to $6.34 through 2034. The $3.46 average target implies a +76% move from current prices. That is up +7% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The PALI price prediction for 2035 points to an average of $4.77 (low $2.67, high $8.94) — a potential gain of +144% on today's $1.96. Momentum favours further upside here.
In 2040, PALI is projected to trade between $2.53 and $10.64, averaging $5.21 — a potential gain of +166% from today's $1.96. That is up +9% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Palisade Bio, Inc.'s 2050 outlook centres on $10.53, within a $4.74 to $24.23 range. That is up +102% on the projected 2040 average. That marks a +437% change versus current levels. Momentum favours further upside here.
Investing $1,000 in PALI today (≈ 510.204082 PALI) could be worth
$5,374.36
+$4,374.36 (+437%) by 2050 · US Dollar
Based on the average projected PALI price of $10.53 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in PALIwould be worth at today's price.
$1,000 invested in PALI on Jul 10, 2025 (≈ 1,282.051329 PALI) would be worth
$2,512.82
+$1,512.82 (+151.3%) today · 2.51× · US Dollar
Based on a PALI entry price of $0.78 vs. today's $1.96.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.1 | $933.33 | -6.7% |
| 1 month ago | $1.68 | $1,166.67 | +16.7% |
| 3 months ago | $1.82 | $1,076.92 | +7.7% |
| 6 months ago | $1.9 | $1,031.58 | +3.2% |
| 1 year ago | $0.78 | $2,512.82 | +151.3% |
| All time (5.0y) ago | $2,850 | $0.69 | -99.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our PALI forecast.
Our base-case forecast reaches $3.90 around 2035.
Implied market cap at $3.90: $676.96M
The multi-year forecast outlines a bullish trajectory, with the 2030 average price of $3.61 and an ROI of 83.3%. The path continues to 2040, where the average price is projected at $6.12 and the ROI at 210.4%, and then to 2050 with an average price of $12.10 and an ROI of 514%. These figures imply meaningful upside across the 2028–2050 horizon, with sentiment remaining BULLISH by 2030, 2040, and 2050.
These are estimates, not guarantees, and carry typical market risks.
Tap a question to reveal the answer.
Avg price $3.61; Min $2.26; Max $6.20; ROI 83.3%; sentiment BULLISH.
Forecasts show a bullish trajectory with 2030 avg $3.61 and 2050 avg $12.10, ROI 83.3% and 514% respectively, but these are estimates, not guarantees.
2035 max $10.89; 2040 max $13.20.
Sentiment BULLISH; RSI14 50; SMA50 $1.94; SMA200 $1.83; support $1.68; resistance $2.23; 30-day range $1.40–$2.77.
Current price $1.97; Market cap $342.35M.
Palisade Bio, Inc. Community Discussion
0Share your Palisade Bio, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.